Pacific Biosciences of California, Inc. approved an amendment to their 2020 Equity Incentive Plan to reserve an additional 20,000,000 shares of common stock for issuance, and the stockholders approved amendments to the company's Certificate of Incorporation to declassify the Board and limit the liability of certain officers.